Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| General Hospital of Nikaia "Saint Panteleimon" | OTHER |
| University Clinical Centre of Kosova | OTHER |
| University Hospital, Ghent | OTHER |
| Szeged University |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to provide conclusive clinical evidence as to whether or not the preoperative administration of oral carbohydrate-rich solutions is effective on the outcomes of patients undergoing colorectal surgery.
Preoperative oral carbohydrate loading is an issue that has been investigated extensively in terms of its fundamental and biochemically apparent effects and potential benefits. Most commonly, proponents of the application advocate that it may be beneficial for improving patient outcomes and for decreasing complication rate by attenuating postoperative insulin resistance. To date, however, no study with a sufficient sample size has been able to demonstrate that it has a marked value in clinical practice. Almost all of the clinical benefits ascribed to the application have been based on subjective well-being, which can also be provided with non specific simple beverages. A study conducted to show whether or not the application has direct influence on patient outcome, therefore, could significantly contribute insights on this topic. The present study was planned to consist of three study arms, namely: 1.Study group, which will be given high-carbohydrate beverage (Nutricia preOp®, Numico, Zoetermeer, The Netherlands) 2. Placebo group, which will be given flavored water, and 3. Control group (surgery after overnight fast). The revised power analysis shows that an accrual of 74 patients in each group would allow detecting a 15% difference in the rate of complications with 80% power at the 5% level of significance (two tailed). We hope we will have recruited at least 220 subjects at the end of a two-year course. Once the data recording is complete, this study will be the largest one ever conducted to investigate this topic.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental | High-carbohydrate |
|
| 2 | Placebo Comparator | Placebo |
|
| 3 | No Intervention | Control |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| commercially available high-carbohydrate beverage | Dietary Supplement | 800 ml before the day of surgery, and additional 400 ml two hours prior to surgery |
|
| Measure | Description | Time Frame |
|---|---|---|
| Overall 30-day complication rate | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Patient discomfort | 2 years | |
| need for insulin infusion | 2 years | |
| Length of intensive care unit and hospital stay |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mehmet F Can, Assist Prof | Gulhane School of Medicine, Department of Surgery | Study Director |
| Avdyl Krasniqi, MD, PhD | University Clinical Centre of Kosova, Department of Surgery | Principal Investigator |
| Costas Vagianos, Assoc Prof | Agios Panteleimon Regional Hospital, Deparment of Surgery | Principal Investigator |
| Gokhan Yagci, Assoc Prof | Gulhane School of Medicine, Department of Surgery | Principal Investigator |
| Gyorgy Lazar, Prof | University of Szeged, Department of Surgery | Principal Investigator |
| Wim P Ceelen, MD, PhD, Prof | Ghent University Hospital, Department of Surgery | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Gulhane School of Medicine | Ankara | 06018 | Turkey (Türkiye) |
Not provided
| ID | Term |
|---|---|
| D005215 | Fasting |
| ID | Term |
|---|---|
| D005247 | Feeding Behavior |
| D001519 | Behavior |
Not provided
Not provided
| OTHER |
| European Society for Surgical Research | OTHER |
Not provided
Not provided
Not provided
Not provided
| flavored water | Dietary Supplement | will be given in doses equal to those of high-carbohydrate beverage |
|
| 2 years |
| Patient recovery | 2 years |
| Overall 30-day mortality rate | 2 years |